Influenza h7n9 lah-hbc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses | |
Zheng, Dan1; Chen, Shaoheng1; Qu, Di2; Chen, Jianjun3; Wang, Fuyan4; Zhang, Ran5; Chen, Ze1,5 | |
刊名 | Vaccine |
2016-12-12 | |
卷号 | 34期号:51页码:6464-6471 |
关键词 | Influenza H7n9 Lah-hbc vlp Adjuvant |
ISSN号 | 0264-410X |
DOI | 10.1016/j.vaccine.2016.11.026 |
通讯作者 | Chen, ze(chenze2005@hotmail.com) |
英文摘要 | The long alpha-helix (lah) region located in influenza virus hemagglutinin (ha) shows conservation among different influenza a strains, which could be used as a candidate target of influenza vaccines. moreover, the hepatitis b virus core protein (hbc) is a carrier for heterologous epitopes in eliciting effective immune responses. we inserted the lah region of h7n9 influenza virus into the hbc and prepared the lah-hbc protein, which were capable of self-assembly into virus-like particles (vlp), by using e. coli expression system. intranasal immunization of the lah-hbc vlp in combination with chitosan adjuvant or ctb* adjuvant in mice could induce both humoral and cellular immune responses effectively and provide complete protection against lethal challenge of homologous h7n9 virus or heterologous h3n2 virus, as well as partial protection against lethal challenge of heterologous h1n1 virus. these results provide a proof of concept for lah-hbc vlp vaccine that would be fast and easy to be produced and might be an ideal candidate as a rapid-response tool against a future influenza pandemic. (c) 2016 elsevier ltd. all rights reserved. |
WOS关键词 | TOXIN-B SUBUNIT ; IMMUNOGLOBULIN-A ; INTRACELLULAR NEUTRALIZATION ; CROSS-PROTECTION ; ANTIBODIES ; INDUCTION ; INFECTION ; CHALLENGE ; EPITOPES ; IMMUNITY |
WOS研究方向 | Immunology ; Research & Experimental Medicine |
WOS类目 | Immunology ; Medicine, Research & Experimental |
语种 | 英语 |
出版者 | ELSEVIER SCI LTD |
WOS记录号 | WOS:000390506100003 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2373485 |
专题 | 武汉病毒研究所 |
通讯作者 | Chen, Ze |
作者单位 | 1.Shanghai Inst Biol Prod, Shanghai 200052, Peoples R China 2.Fudan Univ, Biosafety Level Lab 3, Shanghai 200032, Peoples R China 3.Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China 4.Cent S Univ, Xiangya Sch Med, Dept Immunol, Changsha 410078, Hunan, Peoples R China 5.Hunan Normal Univ, Coll Med, Changsha 410013, Hunan, Peoples R China |
推荐引用方式 GB/T 7714 | Zheng, Dan,Chen, Shaoheng,Qu, Di,et al. Influenza h7n9 lah-hbc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses[J]. Vaccine,2016,34(51):6464-6471. |
APA | Zheng, Dan.,Chen, Shaoheng.,Qu, Di.,Chen, Jianjun.,Wang, Fuyan.,...&Chen, Ze.(2016).Influenza h7n9 lah-hbc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.Vaccine,34(51),6464-6471. |
MLA | Zheng, Dan,et al."Influenza h7n9 lah-hbc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses".Vaccine 34.51(2016):6464-6471. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论